Lawsuit against a dentist related to serious ocular infection possibly linked to water from a dental handpiece

Journal of the Canadian Dental Association

Volumn 73, Issue 7, 2007, Pages 618-622

  Barbeau, Jean ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACANTHAMOEBA; AMEBIASIS; ANIMAL; ARTICLE; CASE REPORT; DENTAL EQUIPMENT; EYE INFECTION; FEMALE; HUMAN; INFECTION CONTROL; ISOLATION AND PURIFICATION; LEGAL ASPECT; PARASITOLOGY; WATER SUPPLY;

ACANTHAMOEBA; AMEBIASIS; ANIMALS; DENTAL EQUIPMENT; EYE INFECTIONS; FEMALE; HUMANS; INFECTION CONTROL, DENTAL; WATER SUPPLY;

EID: 34848874021     PISSN: 07098936     EISSN: 14882159     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Martin MV. The significance of the bacterial contamination of dental unit water systems. Br Dent J 1987; 163(5):152-4.
2. Atlas RM, Williams JF, Huntington MK. Legionella contamination of dental-unit waters. Appl Environ Microbiol 1995; 61(4):1208-13.
3. Schuster FL, Visvesvara GS. Free-living amoebae as opportunistic and non-opportunistic pathogens of humans and animals. Int J Parasitol 2004; 34(9):1001-27.
4. Barbeau J, Buhler T. Biofilms augment the number of free-living amoebae in dental unit waterlines. Res Microbiol 2001; 152(8):753-60.
5. Petty TL. Infection prevention and control in the dental office: an opportunity to improve safety and compliance. Canadian Dental Association. Committee on Clinical and Scientific Affairs; 2006.
6. Barbeau J, Tanguay R, Faucher E, Avezard C, Trudel L, Cote L, and other. Multiparametric analysis of waterline contamination in dental units. Appl Environ Microbiol 1996; 62(11):3954-9.
7. Michel R, Borneff M. [The significance of amoebae and other protozoa in water conduit systems in dental units]. Zentralbl Bakteriol Mikrobiol Hyg [B] 1989; 187(4-6):312-23. [Article in German].
8. Michel R, Just HM. [Acanthamoebae, Naegleria and other free-living Amoebae in cooling and rinsing water of dental treatment units]. Zentralbl Bakteriol Mikrobiol Hyg [B] 1984; 179(1):56-72. [Article in German].
9. Seal DV. Acanthamoeba keratitis update - incidence, molecular epidemiology and new drugs for treatment. Eye 2003; 17(8):893-905.
10. Marciano-Cabral F, Cabral G. Acanthamoeba spp. as agents of disease in humans. Clin Microbiol Rev 2003; 16(2):273-307.
11. Meier PA, Mathers WD, Sutphin JE, Folberg R, Hwang T, Wenzel RP. An epidemic of presumed Acanthamoeba keratitis that followed regional flooding. Results of a case-control investigation. Arch Ophthalmol 1998; 116(8):1090-4.
12. Weissman-Fickler c. Bouzaglo, 2004 CanLII 646 (QC C.S.). Available from URL: www.canlii.org/qc/jug/qccs/2004/2004qccs13261.html.
13. Levin ML, Maddrey WC, Wands JR, Mendeloff AL. Hepatitis B transmission by dentists. JAMA 1974; 228(9):1139-40.
14. Centers for Disease Control (CDC). Recommendations for prevention of HIV transmission in health-care settings. MMWR Morb Mortal Wkly Rep 1987; 36(Suppl 2):1S-18S.
15. Palca J. The case of the Florida dentist. Science 1992; 255(5043):392-4.
16. CDC reports 6th Acer patient diagnosed with HIV. [News Update] J Can Dent Assoc 1993; 59(7):573.
17. Barbeau J. Waterborne biofilms and dentistry: the changing face of infection control. J Can Dent Assoc 2000; 66(10):539-41.
18. American Dental Association. ADA Positions and Statements. ADA Statement on Dental Unit Waterlines. July 2004. Available from URL : www.ada.org/prof/ resources/positions/statements/lines.asp.
19. Organization for Safety and Asepsis Procedures. Dental unit waterlines: OSAP recommendations to clinicians. Available from URL : www.osap.org/ displaycommon.cfm?an=1&subarticlenbr=27.
20. Kohn WG, Collins AS, Cleveland JL, Harte JA, Eklund KJ, Malvitz DM; Centers for Disease Control and Prevention (CDC). Guidelines for infection control in dental health-care settings - 2003. MMWR Recomm Rep 2003; 52(RR-17):1-61.
21. Wilson K, Wilson M, Hebert PC, Graham I. The application of the precautionary principle to the blood system: the Canadian blood system's vCJD donor deferral policy. Transfus Med Rev 2003; 17(2):89-94.
22. Foster KR, Vecchia P, Repacholi MH. Risk management. Science and the precautionary principle. Science 2000; 288(5468):979-81.
23. ElSaadany S, Giulivi A. Comprehensive risk assessment for vCJD in France and other countries for Canadians and the Canadian blood supply. Blood Borne Pathogens Division. Health Canada, June 26, 2000.